Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T van Gelder

Showing results (111-120 of 169) with videos related to

Pageof 17
Sort By:
Transplantation Proceedings|March 27, 2001
Proteinuria and death risk in the renal transplant populationJ I Roodnat, P G Mulder, J Rischen-Vos, et al.
Clinical Transplantation|February 29, 2000
A longitudinal study of TGF-beta1 protein levels in renal allograft recipients converted from CsA to MMF or AZAB J van der Mast, N M van Besouw, P de Kuiper, et al.
Immunopharmacology|September 1, 1995
Pharmacodynamics of prophylactic antirejection therapy with an anti interleukin-2 receptor monoclonal antibody (BT563) after heart and kidney transplantationC J Hesse, T van Gelder, L M Vaessen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1995
Dopamine-producing paraganglioma not visualized by iodine-123-MIBG scintigraphyT van Gelder, G T Verhoeven, P de Jong, et al.
Transplantation|July 15, 1996
A randomized trial comparing safety and efficacy of OKT3 and a monoclonal anti-interleukin-2 receptor antibody (BT563) in the prevention of acute rejection after heart transplantationT van Gelder, A H Balk, F A Jonkman, et al.
Clinical Pharmacology and Therapeutics|February 22, 2008
Renal function as a predictor of irinotecan-induced neutropeniaF A de Jong, J M van der Bol, R H J Mathijssen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 27, 1999
Effect of mycophenolate mofetil on erythropoiesis in stable renal transplant patients is correlated with mycophenolic acid trough levelsN M van Besouw, B J van der Mast, P J Smak Gregoor, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 17, 1998
Redundancy of the cytokine network in the development of rejection after clinical heart transplantationC C Baan, C H Holweg, T van Gelder, et al.
International Journal of Clinical Pharmacy|September 26, 2025
Implementation fidelity of a pharmacist-led intervention program to improve a high serum phosphate concentration in haemodialysis patients: a mixed-methods studyF J van den Oever, E C Vasbinder, Y C Schrama, et al.
International Journal of Medical Informatics|November 12, 2020
Comparison of two algorithms to support medication surveillance for drug-drug interactions between QTc-prolonging drugsFlorine A Berger, Heleen van der Sijs, T van Gelder, et al.
Pageof 17

Showing results (111-120 of 169) with videos related to

Sort By:
Pageof 17
Transplantation Proceedings|March 27, 2001
Proteinuria and death risk in the renal transplant populationJ I Roodnat, P G Mulder, J Rischen-Vos, et al.
Clinical Transplantation|February 29, 2000
A longitudinal study of TGF-beta1 protein levels in renal allograft recipients converted from CsA to MMF or AZAB J van der Mast, N M van Besouw, P de Kuiper, et al.
Immunopharmacology|September 1, 1995
Pharmacodynamics of prophylactic antirejection therapy with an anti interleukin-2 receptor monoclonal antibody (BT563) after heart and kidney transplantationC J Hesse, T van Gelder, L M Vaessen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1995
Dopamine-producing paraganglioma not visualized by iodine-123-MIBG scintigraphyT van Gelder, G T Verhoeven, P de Jong, et al.
Transplantation|July 15, 1996
A randomized trial comparing safety and efficacy of OKT3 and a monoclonal anti-interleukin-2 receptor antibody (BT563) in the prevention of acute rejection after heart transplantationT van Gelder, A H Balk, F A Jonkman, et al.
Clinical Pharmacology and Therapeutics|February 22, 2008
Renal function as a predictor of irinotecan-induced neutropeniaF A de Jong, J M van der Bol, R H J Mathijssen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 27, 1999
Effect of mycophenolate mofetil on erythropoiesis in stable renal transplant patients is correlated with mycophenolic acid trough levelsN M van Besouw, B J van der Mast, P J Smak Gregoor, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 17, 1998
Redundancy of the cytokine network in the development of rejection after clinical heart transplantationC C Baan, C H Holweg, T van Gelder, et al.
International Journal of Clinical Pharmacy|September 26, 2025
Implementation fidelity of a pharmacist-led intervention program to improve a high serum phosphate concentration in haemodialysis patients: a mixed-methods studyF J van den Oever, E C Vasbinder, Y C Schrama, et al.
International Journal of Medical Informatics|November 12, 2020
Comparison of two algorithms to support medication surveillance for drug-drug interactions between QTc-prolonging drugsFlorine A Berger, Heleen van der Sijs, T van Gelder, et al.
Pageof 17